human fibrinogen
PolandDrugs containing this active substance
-
It is a tissue adhesive used in plastic and reconstructive surgery, as well as in the treatment of burns. It is used, among other things, for bonding skin grafts or flaps and for adhering artificial skin to the wound site.
Form: solution for preparation of tissue adhesive
Active substance Dosage human fibrinogen 1 mg/ml aprotinin 3000 KIU/ml calcium chloride dihydrate 40 mcmol/ml human thrombin 4 j.m./ml Manufacturer: Takeda Manufacturing Austria AG
-
The medicine is used for the treatment of bleeding episodes and for prophylaxis during surgical procedures in individuals with congenital fibrinogen deficiency. It is also used to supplement fibrinogen deficiency in patients with severe, uncontrolled bleeding acquired during surgery.
Form: powder and solvent for solution for injection and infusion
Active substance Dosage human fibrinogen 1 g ATC: B02BB01
Manufacturer: Octapharma AB Octapharma GmbH Octapharma Pharmazeutika Produktionsges.m.b.H.
-
Riastap is used to treat bleeding in individuals with congenital fibrinogen deficiency, which causes an increased tendency to bleed.
Form: powder for preparation of solution for injection or infusion
Active substance Dosage human fibrinogen 1 g ATC: B02BB01
Manufacturer: CSL Behring GmbH
-
It is a two-component tissue adhesive used by surgeons as a support when standard methods are insufficient. It helps improve blood clotting, serves as an adhesive to facilitate wound healing, acts as a sealant for sutures in vascular and gastrointestinal surgery, or for adhering tissues, e.g., when fixing skin grafts.
Form: powder and solvent for preparation of tissue adhesive solution
Active substance Dosage aprotinin 3000 KIU calcium chloride dihydrate 40 mcmol human fibrinogen 91 mg human thrombin 500 j.m. ATC: V03A
Manufacturer: Takeda Manufacturing Austria AG